Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma

Details for Australian Patent Application No. 2007256377 (hide)

Owner ProteoSys AG

Inventors Schrattenholz, Andre

Agent Davies Collison Cave

Pub. Number AU-B-2007256377

PCT Pub. Number WO2007/141043

Priority 60/812,089 09.06.06 US; 60/859,489 17.11.06 US

Filing date 11 June 2007

Wipo publication date 13 December 2007

Acceptance publication date 1 November 2012

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 38/00 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/141043 Priority application(s): WO2007/141043

1 November 2012 Application Accepted

  Published as AU-B-2007256377

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007256383-Method for identifying whether a patient will be responder or not to immunotherapy

2007256373-1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use for the manufacture of medicaments